Innovative assessment for skin cancer risk

News and Events

Stay informed and up-to-date on skin cancer risk detection with the latest press releases from DermaSensor. Learn more about company announcements, news and upcoming events.

Request a Demo Today

Press Releases

DermaSensor Announces Class IIb CE Mark and Collaboration with NHS, Marking the Beginning of Its Global Expansion

Jun 10, 2026 4 min read

Press Releases

Advanced Skin Cancer Diagnostic Technology in Clinical Settings

Feb 15, 2026 2 min read

Press Releases

Two New Studies Show DermaSensor™ Devices’ Consistent Performance and Improvements to Physicians’ Melanoma Detection

Nov 2, 2025 5 min read

Press Releases

DermaSensor Secures $16M to Scale AI-Powered Skin Cancer Detection in Primary Care

Oct 2, 2025 4 min read

Press Releases

Published FDA Pivotal Studies Find DermaSensor has 96% Sensitivity and Cuts Physician’s Missed Skin Cancers by Half

Jun 12, 2025 4 min read

Press Releases

DermaSensor Welcomes Carolyn Walsh as Chief Commercial Officer and Announces Commercial Advisory Board

May 15, 2025 4 min read

Press Releases

DermaSensor Receives Three Prestigious Awards in Q4 2024, Solidifying Its Position as a Global Skin Health Leader

Nov 20, 2024 3 min read

Press Releases

DermaSensor in TIME’s List of the Best Inventions of 2024

Oct 30, 2024 3 min read

Press Releases

DermaSensor Announces New Publication Demonstrating its AI-powered Spectroscopy Device’s High Performance for Patients’ Worrisome Moles

Sep 19, 2024 4 min read

...

Get the latest insights from DermaSensor straight to your inbox

Subscribe to receive news, events, and documents

80-0009.23

News and Events

Press Releases

DermaSensor Announces Class IIb CE Mark and Collaboration with NHS, Marking the Beginning of Its Global Expansion

Advanced Skin Cancer Diagnostic Technology in Clinical Settings

Two New Studies Show DermaSensor™ Devices’ Consistent Performance and Improvements to Physicians’ Melanoma Detection

DermaSensor Secures $16M to Scale AI-Powered Skin Cancer Detection in Primary Care

Published FDA Pivotal Studies Find DermaSensor has 96% Sensitivity and Cuts Physician’s Missed Skin Cancers by Half

DermaSensor Welcomes Carolyn Walsh as Chief Commercial Officer and Announces Commercial Advisory Board

DermaSensor Receives Three Prestigious Awards in Q4 2024, Solidifying Its Position as a Global Skin Health Leader

DermaSensor in TIME’s List of the Best Inventions of 2024

DermaSensor Announces New Publication Demonstrating its AI-powered Spectroscopy Device’s High Performance for Patients’ Worrisome Moles

Get the latest insights from DermaSensor straight to your inbox

Stay Informed with DermaSensor